"Designing Growth Strategies is in our DNA"

Recombinant DNA Technology Market Size, Share and Global Trend By Product (Vaccines, Therapeutic Agents, Recombinant Protein, Others), By Component (Vectors, Expression System, Others), By Application (Diagnostics, Therapeutic, Food and Agriculture, Others), By End User (Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Government Research Institutes, Other) and Geography Forecast till 2021-2028

Recombinant DNA technology has successfully established its dominance in the vaccines and medicines. Recombinant DNA technology is also being used for the diagnosis of di... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : | Published Date: Upcoming | Report ID: FBI101016 | Status : Upcoming

 

Request PDF Brochure

Refresh Button
Recombinant DNA Technology Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2014-2018
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X